Carolina Phase 1 Research — Raleigh, North Carolina

Carolina Phase 1 Research is a clinical research site located in Raleigh, North Carolina, United States 27612.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Carolina Phase 1 Research has participated in 6 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus, Rheumatoid Arthritis, Diabetes Melliuts, Type 2.

Sponsors: Pfizer, Astellas Pharma Global Development, Inc., Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Raleigh

Browse all research sites in North Carolina · View every site in Raleigh

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carolina Phase 1 Research?

Carolina Phase 1 Research has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carolina Phase 1 Research conducted?

Carolina Phase 1 Research has 6 clinical trials on record. Their work covers Systemic Lupus Erythematosus, Rheumatoid Arthritis, Diabetes Melliuts, Type 2.

Is Carolina Phase 1 Research accredited by Crixeo Clinical Trials?

Carolina Phase 1 Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carolina Phase 1 Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.